Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2017-06-07 Director's Dealing
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2017-06-07 English
PRIMARY DOCUMENT
Director's Dealing
2017-06-05 English
PRIMARY DOCUMENT
Director's Dealing
2017-06-05 English
PRIMARY DOCUMENT
Director's Dealing
2017-06-01 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated May 18, 2017, reporting the results of the 2017 Annual Meeting of Shareholders of Insmed Incorporated. It details the voting results on several proposals including election of directors, advisory votes on executive compensation, ratification of the independent auditor, and approval of an incentive plan. The content is focused on the submission of matters to a vote of security holders and the official voting outcomes. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is not a full annual report, audit report, or proxy statement, but specifically the official voting results from the shareholder meeting. The document length (5918 characters) and detailed vote counts support this classification with high confidence.
2017-05-22 English
PRIMARY DOCUMENT
Director's Dealing
2017-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.